Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipients

Research output: Contribution to journalArticleAcademicpeer-review

23 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1323-1331
Number of pages9
JournalExpert Review of Clinical Immunology
Volume15
Issue number12
DOIs
Publication statusPublished - 2019

Research programs

  • EMC MM-04-39-05

Cite this